Duke Ohashi

Duke Ohashi is a seasoned clinical operations professional with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as Associate Director of Clinical Operations at Lineage Cell Therapeutics, Duke oversees ClinOps and leads the OPC1 and OpRegen assets. Previous roles include Senior Clinical Study Manager at CSL Behring, where Duke managed global gene therapy trials, and Site Engagement Manager at UCB, focusing on site engagement strategies. Duke's background also features a substantial tenure at Puma Biotechnology, where responsibilities ranged from Clinical Trial Manager to Clinical Research Associate, as well as roles at IQVIA, Kyowa Kirin, and the University of California San Diego. Duke holds a B.S. in Biology with a minor in Psychology from UC San Diego.